These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
602 related items for PubMed ID: 18570328
1. Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping. Madden HR, Fletcher S, Davis MR, Wilton SD. Hum Mutat; 2009 Jan; 30(1):22-8. PubMed ID: 18570328 [Abstract] [Full Text] [Related]
3. Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscle. Popplewell LJ, Graham IR, Malerba A, Dickson G. Methods Mol Biol; 2011 Jan; 709():153-78. PubMed ID: 21194027 [Abstract] [Full Text] [Related]
7. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Aartsma-Rus A, Fokkema I, Verschuuren J, Ginjaar I, van Deutekom J, van Ommen GJ, den Dunnen JT. Hum Mutat; 2009 Mar; 30(3):293-9. PubMed ID: 19156838 [Abstract] [Full Text] [Related]
8. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Gurvich OL, Tuohy TM, Howard MT, Finkel RS, Medne L, Anderson CB, Weiss RB, Wilton SD, Flanigan KM. Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005 [Abstract] [Full Text] [Related]
10. Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons. Aartsma-Rus A, Kaman WE, Weij R, den Dunnen JT, van Ommen GJ, van Deutekom JC. Mol Ther; 2006 Sep; 14(3):401-7. PubMed ID: 16753346 [Abstract] [Full Text] [Related]
11. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy. Takeshima Y, Yagi M, Wada H, Ishibashi K, Nishiyama A, Kakumoto M, Sakaeda T, Saura R, Okumura K, Matsuo M. Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883 [Abstract] [Full Text] [Related]
14. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle. Takeshima Y, Yagi M, Wada H, Matsuo M. Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206 [Abstract] [Full Text] [Related]
15. Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing. Takeshima Y, Yagi M, Matsuo M. Methods Mol Biol; 2012 Oct; 867():131-41. PubMed ID: 22454059 [Abstract] [Full Text] [Related]
16. Induced dystrophin exon skipping in human muscle explants. McClorey G, Fall AM, Moulton HM, Iversen PL, Rasko JE, Ryan M, Fletcher S, Wilton SD. Neuromuscul Disord; 2006 Oct; 16(9-10):583-90. PubMed ID: 16919955 [Abstract] [Full Text] [Related]
17. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR, Hill VJ, Manoharan M, Inamati GB, Dickson G. J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737 [Abstract] [Full Text] [Related]
18. Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy. Mann CJ, Honeyman K, McClorey G, Fletcher S, Wilton SD. J Gene Med; 2002 Oct; 4(6):644-54. PubMed ID: 12439856 [Abstract] [Full Text] [Related]